Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Bioject Medical Tech. (NasdaqNM:BJCT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider
Recent Events
July 26Conference call: Bioject Medical Technologies Earnings (Q1 2002)
Location
7620 S.W. Bridgeport Road
Portland, OR 97224
Phone: (503) 639-7221
Fax: (503) 624-9002
Email: kmr@bioject.com
Employees (last reported count): 42
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 45%
·Over the last 6 months:
 · 6 insider buys; 21.0K shares (0.5% of insider shares)
·Institutional: 24% (43% of float)
(20 institutions)
·Net Inst. Buying: 575.0K shares (+19.74%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Bioject Medical Technologies Inc. was incorporated in 1985 for the purpose of developing, manufacturing and marketing jet injection systems for needle-free drug delivery. The Company licenses its technology to pharmaceutical and biotechnology companies for whose products the Company's technology provides enhanced market acceptance or increased medical efficacy. The Company also sells its products directly to healthcare providers. Since its formation, the Company has been engaged principally in organizational, financing, research and development, and marketing activities. Its products and manufacturing operations are subject to extensive government regulation, both in the United States and abroad.
More from Market Guide: Expanded Business Description

Financial Summary
Bioject Medical Technologies develops, manufactures and markets a jet injection system for needle-free drug delivery. For the three months ended 6/30/01, revenues rose 20% to $620 thousand. Net loss applicable to Common increased 10% to $1.4 million. Revenues reflect an increase in unit sales volumes of Serono related products. Higher loss suffered from costs related to the Iject disposable and other new products developments and increased S/G/A costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2001 Pay

James O'Shea, 56
Chairman, Pres, CEO
$256K
J. Michael Redmond, 41
VP, Bus. Devel. of Bioject Inc.
195K
Richard Stout, M.D., 48
VP of Clinical Affairs of Bioject Inc.
122K
Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BJCTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 27-Dec-2000
$4.25 
Recent Price$13.00 
52-Week High
on 8-June-2001
$14.90 
Beta1.32 
Daily Volume (3-month avg)44.5K
Daily Volume (10-day avg)109.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+51.8%
52-Week Change
relative to S&P500
+103.7%
Share-Related Items
Market Capitalization$127.5M
Shares Outstanding9.81M
Float5.40M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 5 on 13-Oct-1999
Per-Share Data
Book Value (mrq)$1.51 
Earnings (ttm)-$0.78 
Earnings (mrq)-$0.16 
Sales (ttm)$0.27 
Cash (mrq)$2.66 
Valuation Ratios
Price/Book (mrq)8.61 
Price/EarningsN/A 
Price/Sales (ttm)48.46 
Income Statements
Sales (ttm)$2.14M
EBITDA (ttm)-$5.39M
Income available to common (ttm)-$6.15M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-25.41%
Return on Equity (ttm)-228.11%
Financial Strength
Current Ratio (mrq)24.82 
Debt/Equity (mrq)0 
Total Cash (mrq)$26.1M
Short Interest
As of 8-Aug-2001
Shares Short70.0K
Percent of Float1.3%
Shares Short
(Prior Month)
115.0K
Short Ratio2.12 
Daily Volume33.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.